52 results on '"Stefan, Norbert"'
Search Results
2. Automated shape-independent assessment of the spatial distribution of proton density fat fraction in vertebral bone marrow
3. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
4. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
5. A global research priority agenda to advance public health responses to fatty liver disease
6. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
7. The role of hepatokines in NAFLD
8. A global view of the interplay between non-alcoholic fatty liver disease and diabetes
9. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance
10. Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
11. Causes, consequences, and treatment of metabolically unhealthy fat distribution
12. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
13. Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study
14. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits
15. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
16. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
17. Correlation of Brown Adipose Tissue with Other Body Fat Compartments and Patient Characteristics: A Retrospective Analysis in a Large Patient Cohort Using PET/CT
18. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
19. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
20. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
21. Phenotypes of prediabetes and stratification of cardiometabolic risk
22. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
23. Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans
24. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes
25. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes
26. Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1
27. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
28. Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion
29. The genetic influence on body fat distribution
30. Impact of higher BMI on cardiometabolic risk: does height matter?
31. Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes
32. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
33. RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study
34. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals
35. Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus
36. The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals
37. Achieving replicable subphenotypes of adult-onset diabetes – Authors' reply
38. Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight
39. Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala
40. Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes
41. Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans
42. Invited talk: Prediabetes phenotypes improve prediction and prevention of type 2 diabetes
43. Invited talk: The role of NAFLD and hepatokines in metabolism
44. Invited talk: Recognising NAFLD and what should be done?
45. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
46. RETRACTED: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes
47. Nonalcoholic Fatty Liver Disease and Mortality
48. Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus
49. Global trends in body-mass index
50. High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.